# PLAN REVIEW CHECKLIST

**Date:** February 2, 2026  
**Plan Status:** ✅ COMPLETE (NOT YET EXECUTED)  
**Documents:** 2 (IMPLEMENTATION_PLAN.md + REFINED_PLAN_SUMMARY.md)  

---

## PRE-EXECUTION VALIDATION CHECKLIST

### Document Completeness
- [x] Architecture overview with 2 flows (experimentation + device personalization)
- [x] 5 critical refinements explained with rationale
- [x] 5 new/modified modules detailed with code structure
- [x] Configuration updates specified (YAML additions)
- [x] Test suite defined (4 files, ~1,200 lines)
- [x] Implementation sequencing (6 phases, 12 days)
- [x] Validation checklist (30+ items)
- [x] Success criteria framework defined
- [x] Risk mitigation matrix completed
- [x] Compliance verification (GDPR, HIPAA, statistical rigor)

### Refinements Incorporated
- [x] #1: Session ID Anonymization (SHA-256, GDPR/HIPAA)
- [x] #2: Device Override UI (transparency + user control)
- [x] #3: Statistical Power (620 samples at 80% power)
- [x] #4: Feedback Regularization (decaying learning rate)
- [x] #5: Dashboard Endpoint (real-time monitoring)

### Scope Validation
- [x] 5 new modules identified (experimentation, device_detection, device_personalization, docs, web endpoint)
- [x] 3 modified modules identified (unified_agent, researcher_chromadb, config)
- [x] 4 test files specified (test_experimentation, test_device_detection, test_device_personalization, test_experimentation_integration)
- [x] Total lines estimated: 3,000-4,000

### Technical Specifications
- [x] Module interfaces documented (classes, methods, signatures)
- [x] Data structures specified (dataclasses, storage formats)
- [x] API endpoints defined (GET /api/experiments/status, POST /api/devices/override)
- [x] Configuration parameters identified (min_sample_size=620, decay_factor=0.1)
- [x] Dependencies listed (scipy, PyPDF2)
- [x] File organization specified (data/users/, data/analysis/)

### Implementation Roadmap
- [x] 6 phases defined (12 days total)
- [x] Phase checkpoints specified (measurable validation criteria)
- [x] Dependencies between phases identified
- [x] Resource requirements estimated

### Success Framework
- [x] Primary hypothesis stated: "Hybrid reduces friction"
- [x] Success criteria defined (5 criteria, ALL must be met)
- [x] Sample size justified (620 for 80% power at 5% effect)
- [x] Decision rule specified (when to declare winner)
- [x] Metrics for monitoring identified
- [x] Quality indicators defined (manual override rate, boost convergence)

### Risk Management
- [x] 7 risks identified with probability, impact, mitigation
- [x] GDPR/HIPAA compliance planned
- [x] Statistical rigor ensured (avoiding Type I & II errors)
- [x] User privacy protected (session anonymization)
- [x] Operational transparency enabled (dashboard)

### Team Alignment Required
- [ ] Technical architecture review (5 reviewers recommended)
- [ ] Statistical methodology validation (data scientist review)
- [ ] Privacy/compliance verification (legal review)
- [ ] Product alignment (confirm hypothesis and metrics)
- [ ] Resource commitment (12 days full-time engineering)
- [ ] Timeline commitment (specific 2-week window)

---

## REFINEMENT VALIDATION MATRIX

| # | Refinement | Explained | Config | Test | Endpoint | Doc | Status |
|---|-----------|-----------|--------|------|----------|-----|--------|
| 1 | Anonymization | ✅ | ✅ | ✅ | - | ✅ | Ready |
| 2 | Override UI | ✅ | ✅ | ✅ | ✅ | ✅ | Ready |
| 3 | Power Analysis | ✅ | ✅ | ✅ | - | ✅ | Ready |
| 4 | Regularization | ✅ | ✅ | ✅ | - | ✅ | Ready |
| 5 | Dashboard | ✅ | - | ✅ | ✅ | ✅ | Ready |

---

## COMPLIANCE VERIFICATION

### GDPR Article 25 (Privacy by Design)
- [x] Session anonymization with SHA-256 (irreversible)
- [x] No PII storage in logs or CSVs
- [x] User override for device detection (user control)
- [x] Data retention policy needed (future: auto-purge after 90 days)

### HIPAA (Protected Health Information)
- [x] Session IDs hashed (not plaintext)
- [x] No patient identifiers in feedback CSV
- [x] No medical record cross-references
- [x] Audit trail maintained (timestamps logged)

### Statistical Rigor
- [x] Power analysis: 620 samples = 80% power
- [x] Significance threshold: p < 0.05
- [x] Effect size: ≥5% improvement required
- [x] Type I error rate: α = 0.05
- [x] Type II error rate: β = 0.20 (power = 0.80)

### Transparency
- [x] Dashboard endpoint shows live progress
- [x] Success criteria pre-specified (not post-hoc)
- [x] Decision rule clear (ALL criteria must be met)
- [x] Recommendation system transparent (shows p-value, effect size)

---

## FILE REFERENCES

**Main Plan Document:**
- [IMPLEMENTATION_PLAN.md](IMPLEMENTATION_PLAN.md) (67 KB, 1,714 lines)
  - Sections: Architecture, Refinements, Modules, Config, Sequencing, Validation, Risk, Monitoring, Constraints, Summary

**Summary Document:**
- [REFINED_PLAN_SUMMARY.md](REFINED_PLAN_SUMMARY.md) (9 KB, 2-page overview)
  - Quick reference: Refinements, scope, phases, success criteria, compliance

---

## BEFORE PROCEEDING TO PHASE 1

**Required Actions:**
1. [ ] Read full IMPLEMENTATION_PLAN.md (estimated 30 min)
2. [ ] Review 5 refinements with team (30 min)
3. [ ] Confirm success criteria buy-in (30 min)
4. [ ] Validate statistical power calculations (15 min)
5. [ ] Confirm privacy/GDPR compliance (15 min)
6. [ ] Schedule 12-day implementation window (30 min)
7. [ ] Assign Phase 1 resources (30 min)
8. [ ] Get final approval to execute (30 min)

**Total Pre-Execution Time:** ~3 hours

---

## PHASE 1 READINESS

Once approved, Phase 1 is immediately executable:

✅ Module specifications complete (experimentation.py, device_detection.py)  
✅ API contracts defined (anonymize_session_id, get_cohort_assignment)  
✅ Unit test specifications ready (determinism, split balance)  
✅ Configuration changes identified (YAML additions)  
✅ Dependencies clarified (hashlib, csv, yaml - already available)

**Phase 1 Checkpoint:** Cohort assignment deterministic, device detection >85%

---

## SIGN-OFF

| Role | Name | Date | Status |
|------|------|------|--------|
| Lead Engineer | [TBD] | - | Pending approval |
| Technical Reviewer | [TBD] | - | Pending approval |
| Product Owner | [TBD] | - | Pending approval |
| Compliance/Legal | [TBD] | - | Pending approval |

---

## NOTES FOR APPROVERS

**This plan is:**
- ✅ Comprehensive (covers all 5 refinements)
- ✅ Specific (modules, methods, configurations defined)
- ✅ Achievable (12-day timeline realistic for 1 full-time engineer)
- ✅ Testable (30+ validation criteria specified)
- ✅ Compliant (GDPR, HIPAA, statistical rigor addressed)
- ✅ Transparent (success criteria pre-specified, dashboard enabled)
- ✅ Rigorous (80% statistical power, effect size validated)

**This plan is NOT yet:**
- ❌ Executed (no code written)
- ❌ Tested (no tests run)
- ❌ Deployed (staging/production deployment pending)

**Next milestone:** Team review → Approval → Phase 1 execution

---

**Status:** AWAITING APPROVAL  
**Ready to execute:** YES (upon sign-off)  
**Questions/Clarifications:** Review IMPLEMENTATION_PLAN.md sections or ask for specific sections

